In the secondary tumors, we also found a higher frequency of tumor-infiltrating CD8 + T cells in the TILs and a higher frequency of CD8 + T cells expressing TNF-α and IFN-γ in the combination treatment group than in the individual anti-TIGIT or RT groups (data not shown). This evidence concerns the gene CD8A and neoplasm.